ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,656, issued on Nov. 4, was assigned to Atea Pharmaceuticals Inc. (Boston).
"Advantageous anti-HCV combination therapy" was invented by Jean-Pierre Sommadossi (Boston), Adel Moussa (Burlington, Mass.), Keith M. Pietropaolo (Boxford, Mass.) and Xiao-Jian Zhou (Arlington, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "A synergistic pharmaceutical combination of Compound 1 or a pharmaceutically acceptable salt thereof (e.g., Compound 1-A) and Compound 2 or a pharmaceutically acceptable salt thereof, as well as its uses to treat hepatitis C or a condition related to hepatitis C, as well as methods for the manufacture of the pharmaceutical combinatio...